Keyphrases
Netherlands
100%
Cost-effectiveness
66%
Age Groups
33%
Smokers
33%
Lung Cancer
33%
Hepatitis C Virus Screening
33%
Ex-smokers
33%
Screening Strategy
33%
Migrants
33%
Neurotoxicity
33%
Therapeutic Drug Monitoring
33%
Valacyclovir
33%
Hospital-based
33%
Quality-adjusted Life Years
27%
Patient-reported Experience Measures
22%
Life-years Gained
19%
Incremental Cost-effectiveness Ratio
19%
Endemic Countries
13%
Hepatitis C Virus
13%
CONSORT-PRO
12%
Plasma Concentration
12%
Acyclovir
12%
Unused Medicines
9%
Lung Cancer Screening
8%
Impaired Kidney Function
8%
Underreported
8%
Mycophenolic Acid
8%
Aciclovir
8%
Elderly Patients
8%
Healthcare Payment
8%
Health Costs
7%
Health Effects
7%
Markov Model
7%
Carer Perspectives
7%
End-user Experience
6%
Personal Care Plan
6%
Budget Impact
6%
Markov Transition
5%
Transition State Models
5%
Medicine and Dentistry
Patient-Reported Outcome
76%
Multiple Myeloma
66%
Quality of Life
33%
Randomized Controlled Trial
33%
Remote Patient Monitoring
33%
Drug Use
33%
Cost-Effectiveness Analysis
33%
Patient Care
33%
Metastatic Colorectal Cancer
33%
Hepatitis C Virus
33%
e-Health
33%
Health Care
33%
Clinical Trial
33%
Drug Therapy
9%
Care Pathway
9%
Disease
8%
Quality Adjusted Life Year
7%
Health Care Cost
7%
